1401, 18e Rue
H-513
Québec, Québec
Canada G1J 1Z4
Dernières nouvelles
Information non disponible
Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia
Article de revueCancer Med, 13 (17), 2024.
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database
Article de revueBlood Cancer J, 13 (1), 2023.
A Phase II, Open-Label Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma
Article de revueClin Lymphoma Myeloma Leuk, 23 (7), 2023.
First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline Consortium
Article de revueClin Lymphoma Myeloma Leuk, 23 (5), 2023.
Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline Consortium
Article de revueClin Lymphoma Myeloma Leuk, 22 (1), 2022.